TP53 and osteosarcoma: Furthermore, the results of immunohistochemistry (IHC) show that the expressions of Bax, PUMA, and p53 were markedly increased in osteosarcoma tissues of TMS + TRAIL treated mice compared with those of the vehicle-treated mice (P < 0.05Figure 9(c)).